Gastroretentive bilayer film for sustained release of atorvastatin calcium and immediate release of amlodipine besylate: pharmaceutical, pharmacokinetic evaluation, and IVIVC
- 26 December 2019
- journal article
- research article
- Published by Taylor & Francis in Pharmaceutical Development and Technology
- Vol. 25 (4) , 416-431
Abstract
The present study was aimed to optimize capsulated unfolding type gastroretentive bilayer film constituting immediate release(IR) layer of amlodipine besylate and sustained release(SR) layer of atorvastatin calcium. A three-factor, three-level Box-Behnken-design was used to optimize bilayer film with dual-release characteristics. The selected independent variables were HPMC-K3, Eudragit RSPO and Carbopol 934P and the responses were floating duration, swelling index, and in-vitro release from SR layer in 8h. The films were also assessed for pharmacotechnical characteristics, release kinetics, DSC, FTIR and SEM. The pharmacokinetics of the drugs from the optimized formulation was compared with the marketed formulation in rabbits. The capsulated accordion film unfolded and provided SR of atorvastatin for 8h(96.76%±0.71) and IR of amlodipine within 25 min(98.07%±0.62) for the optimized formulation(F14). The swelling index and floating duration for the optimized formulation were 140.48 ± 0.57 and 8.53 ± 0.10h respectively. Results of pharmacokinetics showed that faster absorption of amlodipine and improved bioavailability(2.16 fold) of atorvastatin in blood was made available through bilayer film. In-vitro-in-vivo correlation was established using numerical deconvolution method. It can be concluded that the capsulated gastroretentive system provided site specific simultaneous SR of antihyperlidemic drug and IR of antihypertensive drug as single pill that has therapeutic potential to manage cardiovascular risk.Keywords
This publication has 34 references indexed in Scilit:
- Polysaccharides based gastroretentive system to sustain piroxicam release: Development and in vivo prolonged anti-inflammatory effectInternational Journal of Biological Macromolecules, 2018
- Atorvastatin calcium loaded chitosan nanoparticles: in vitro evaluation and in vivo pharmacokinetic studies in rabbitsBrazilian Journal of Pharmaceutical Sciences, 2015
- Development and characterization of newer floating film bearing 5-fluorouracil as a model drugJournal of Drug Delivery Science and Technology, 2014
- Development of novel gastroretentive drug delivery system of gliclazide: hollow beadsDrug Development and Industrial Pharmacy, 2013
- Design of a gastroretentive mucoadhesive dosage form of furosemide for controlled releaseActa Pharmaceutica Sinica B, 2012
- Gastroretentive microparticles for drug delivery applicationsJournal of Microencapsulation, 2011
- Effect of Food on the Bioavailability of Amlodipine Besylate/Atorvastatin Calcium Combination TabletThe Journal of Clinical Pharmacology, 2006
- Floating drug delivery systems: A reviewAAPS PharmSciTech, 2005
- Single‐Pill Therapy in the Treatment of Concomitant Hypertension and Dyslipidemia (The Amlodipine/Atorvastatin Gemini Study)The Journal of Clinical Hypertension, 2005
- Effect of amlodipine?atorvastatin combination on fibrinolysis in hypertensive hypercholesterolemic patients with insulin resistanceAmerican Journal of Hypertension, 2004